Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncology Reports|September 15, 2021
Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinomaJingcheng Hao, Haimin Deng, Yuan Yang, et al.
Plos One|October 7, 2016
The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during ChemotherapyQingqing Cai, Kailin Chen, Jie Chen, et al.
Frontiers in Oncology|January 3, 2022
Efficacy and Safety of Docetaxel and Sodium Cantharidinate Combination vs. Either Agent Alone as Second-Line Treatment for Advanced/Metastatic NSCLC With Wild-Type or Unknown EGFR Status: An Open-Label, Randomized Controlled, Prospective, Multi-Center Phase III Trial (Cando-L1)Lin Wu, Chao Deng, Hui Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2024
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trialXingxiang Pu, Zemin Xiao, Jia Li, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
British Journal of Cancer|December 19, 2023
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancerBolin Chen, Wenxiu Yao, Xingya Li, et al.
Pageof 3